Career Development Program
职业发展计划
基本信息
- 批准号:8764766
- 负责人:
- 金额:$ 6.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-01 至 2018-08-31
- 项目状态:已结题
- 来源:
- 关键词:Academic Medical CentersApplied ResearchBreastClinicalClinical InvestigatorComprehensive Cancer CenterDoctor of PhilosophyFundingGoalsIncidenceKnowledgeLaboratoriesLaboratory ScientistsLeadMentorshipMorbidity - disease ratePathway interactionsPhysiciansProgram DevelopmentRecruitment ActivityResearchResearch PersonnelScientistTalentsTrainingTraining ProgramsTranslational ResearchUnderrepresented MinorityUnited States National Institutes of HealthWomananticancer researchbasecareercareer developmentimprovedmalignant breast neoplasmmortalityprogramsskillssuccess
项目摘要
Vanderbilt University Medical Center (VUMC) and the NCI-designated Vanderbilt-lngram Comprehensive
Cancer Center (VICC) have taken specific actions to improve the quantity and quality of opportunities for
training in translational research available to translational/clinical investigators, laboratory-based physician-scientists
and basic scientists. These actions are of vital importance for the success of the Breast SPORE as
well as for the successful application of progress made in the laboratory to our ultimate goal: a reduction in the
incidence, morbidity and mortality resulting from breast cancer. To achieve these overall goals, the SPORE
includes a Career Development Program (CDP). Specific aims of the CDP are as follows:
To recruit, support and develop young physician-scientists and laboratory-based translational/clinical
investigators (MD and MD/PhD) into breast cancer research
To recruit, support and develop young basic scientists (PhD) into mechanism-based applied research in
breast cancer
To recruit outstanding basic scientists into breast cancer research and provide clinical and translational
expertise to this research
To provide translational research mentorship, training and opportunities for investigators to develop the
knowledge, skills and expertise to successfully pursue independent, extramurally-funded scholarly
careers focused in translational research in breast cancer
To make a high priority the recruitment of women and underrepresented minority investigators into
research in breast cancer
范德比尔特大学医学中心(VUMC)和NCI指定的范德比尔特-英格拉姆综合医院
癌症中心(VICC)已采取具体行动,以提高机会的数量和质量,
为翻译/临床研究者、实验室医生-科学家提供翻译研究培训
和基础科学家。这些行动对于乳房孢子的成功至关重要,
以及成功地将实验室取得的进展应用于我们的最终目标:减少
乳腺癌的发病率、发病率和死亡率。为了实现这些总体目标,
包括职业发展计划(CDP)。该委员会的具体目标如下:
招募,支持和发展年轻的医生,科学家和实验室为基础的翻译/临床
研究人员(MD和MD/PhD)进入乳腺癌研究
招募、支持和培养年轻的基础科学家(博士)从事以机制为基础的应用研究,
乳腺癌
招募优秀的基础科学家进入乳腺癌研究领域,并提供临床和翻译服务。
这项研究的专业知识
为研究人员提供转化研究指导、培训和机会,
知识,技能和专业知识,以成功地追求独立,校外资助的学术
职业生涯集中在乳腺癌的转化研究
高度优先征聘妇女和任职人数不足的少数群体调查员,
乳腺癌的研究
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Carlos L Arteaga其他文献
Methods of Evaluating EGFR Expression The causal role of high expression of HER 2 in cancer
评估 EGFR 表达的方法 HER 2 高表达在癌症中的因果作用
- DOI:
- 发表时间:
2002 - 期刊:
- 影响因子:0
- 作者:
Carlos L Arteaga - 通讯作者:
Carlos L Arteaga
HER3 and mutant EGFR meet MET
HER3 与突变型 EGFR 与 MET 相遇
- DOI:
10.1038/nm0607-675 - 发表时间:
2007-06-01 - 期刊:
- 影响因子:50.000
- 作者:
Carlos L Arteaga - 通讯作者:
Carlos L Arteaga
Selecting the right patient for tumor therapy
为肿瘤治疗选择合适的患者
- DOI:
10.1038/nm0604-577 - 发表时间:
2004-06-01 - 期刊:
- 影响因子:50.000
- 作者:
Carlos L Arteaga - 通讯作者:
Carlos L Arteaga
Carlos L Arteaga的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Carlos L Arteaga', 18)}}的其他基金
Neoadjuvant Neratinib in Stage I-III HER2-mutated Lobular Breast Cancer
新辅助来那替尼治疗 I-III 期 HER2 突变小叶乳腺癌
- 批准号:
10660734 - 财政年份:2023
- 资助金额:
$ 6.58万 - 项目类别:
Role of HER2 mutations in breast cancer progression and response to targeted therapies
HER2 突变在乳腺癌进展和靶向治疗反应中的作用
- 批准号:
9759820 - 财政年份:2018
- 资助金额:
$ 6.58万 - 项目类别:
Role of HER2 mutations in breast cancer progression and response to targeted therapies
HER2 突变在乳腺癌进展和靶向治疗反应中的作用
- 批准号:
10214565 - 财政年份:2018
- 资助金额:
$ 6.58万 - 项目类别:
Role of HER2 mutations in breast cancer progression and response to targeted therapies
HER2 突变在乳腺癌进展和靶向治疗反应中的作用
- 批准号:
10458531 - 财政年份:2018
- 资助金额:
$ 6.58万 - 项目类别:
Role of HER2 mutations in breast cancer progression and response to targeted therapies
HER2 突变在乳腺癌进展和靶向治疗反应中的作用
- 批准号:
9614453 - 财政年份:2018
- 资助金额:
$ 6.58万 - 项目类别:
Inhibition of P13 Kinase as a Strategy to Abrogate Antiestrogen Resistance in Br
抑制 P13 激酶作为消除 Br 抗雌激素耐药性的策略
- 批准号:
8764757 - 财政年份:2014
- 资助金额:
$ 6.58万 - 项目类别:
UT Southwestern Medical Center Simmons Comprehensive Cancer Center
UT 西南医学中心西蒙斯综合癌症中心
- 批准号:
10693201 - 财政年份:2010
- 资助金额:
$ 6.58万 - 项目类别:
UT Southwestern Medical Center Simmons Comprehensive Cancer Center
UT 西南医学中心西蒙斯综合癌症中心
- 批准号:
10477948 - 财政年份:2010
- 资助金额:
$ 6.58万 - 项目类别:
相似海外基金
Applied research towards practical use of Devanagari OCR and utilization of text database
天城文 OCR 实用化和文本数据库利用的应用研究
- 批准号:
23H00564 - 财政年份:2023
- 资助金额:
$ 6.58万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Basic and applied research on extinction bursts when treating problem behavior
处理问题行为时灭绝爆发的基础和应用研究
- 批准号:
10657028 - 财政年份:2023
- 资助金额:
$ 6.58万 - 项目类别:
RFA-CK-23-001, Clinical and Applied Research Strategies for the Prevention and Control of Fungal Diseases
RFA-CK-23-001,真菌病预防和控制的临床和应用研究策略
- 批准号:
10833915 - 财政年份:2023
- 资助金额:
$ 6.58万 - 项目类别:
Fundamental and applied research on dynamic polymer brush system floating on water with high-order responsiveness
高阶响应漂浮于水面的动态聚合物刷系统基础与应用研究
- 批准号:
22KJ0790 - 财政年份:2023
- 资助金额:
$ 6.58万 - 项目类别:
Grant-in-Aid for JSPS Fellows
The 2023 Canadian Centre for Applied Research in Cancer Control (ARCC) Conference
2023年加拿大癌症控制应用研究中心(ARCC)会议
- 批准号:
480786 - 财政年份:2023
- 资助金额:
$ 6.58万 - 项目类别:
Miscellaneous Programs
Discovery and Applied Research for Technological Innovations to ImproveHuman Health
改善人类健康的技术创新的发现和应用研究
- 批准号:
10841979 - 财政年份:2023
- 资助金额:
$ 6.58万 - 项目类别:
Advancing Applied Research and Innovation at Humber College
推进汉伯学院的应用研究和创新
- 批准号:
CCMOB-2021-00023 - 财政年份:2022
- 资助金额:
$ 6.58万 - 项目类别:
CCI Mobilize Grants
Comprehensive research on "Shoen-ezu" survey and analysis methods and applied research on general-purpose historical geographic information
“正圆江津”调查分析方法综合研究及通用历史地理信息应用研究
- 批准号:
22H00016 - 财政年份:2022
- 资助金额:
$ 6.58万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Thriving in the New Economy: A synergistic approach to community and industry partnerships for applied research and capacity building
在新经济中蓬勃发展:应用研究和能力建设的社区和行业伙伴关系的协同方法
- 批准号:
CCMOB-2021-00240 - 财政年份:2022
- 资助金额:
$ 6.58万 - 项目类别:
CCI Mobilize Grants
Industrial Applied Research Chair in Interoperability Sensor Systems for IIoT Applications
IIoT 应用互操作性传感器系统工业应用研究主席
- 批准号:
533812-2018 - 财政年份:2022
- 资助金额:
$ 6.58万 - 项目类别:
Industrial Research Chairs for Colleges Grants














{{item.name}}会员




